30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mike Anderson

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 66% 68% 82%
Transactions
6 83% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -51%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chief Executive Officer, Director Avadel Pharmaceuticals PLC June 22, 2012 - Dec. 30, 2018
Chief Executive Officer Avadel Pharmaceuticals PLC March 13, 2012 - June 22, 2012
Mike Anderson's trades of Avadel Pharmaceuticals PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2018-08-14 2018-08-10
S Sale
89,476 +3.4%
187.41
US$877,762 		89,476 +3.4% 187.41 US$877,762
2018-06-27 2018-06-26
B Purchase
54,904 +12.5%
164.61
US$1,173,140 		54,904 +12.5% 164.61 US$1,173,140
2016-09-07 2016-09-02
B Purchase
59,941 +21.5%
253.35
US$2,856,635 		59,941 +21.5% 253.35 US$2,856,635
2016-05-16 2016-05-12
B Purchase
5,000 +3.9%
8.84
US$44,200 		5,000 +3.9% 8.84 US$44,200
2016-03-21 2016-03-18
B Purchase
5,000 +4.0%
11.04
US$55,220 		5,000 +4.0% 11.04 US$55,220
2016-03-16 2016-03-14
B Purchase
10,000 +8.8%
9.74
US$97,350 		10,000 +8.8% 9.74 US$97,350